Schizoaffective Disorder trials recruiting in Georgia

All Schizoaffective Disorder trials nationally

Cities in Georgia

Recruiting trials in Georgia

• A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
  NCT07105111 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Augusta, Marietta
• Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
  NCT06740383 · Phase: Not specified · Ages: 18 Years to 40 Years · Sex: All (male and female) · Georgia: Athens
• CLOZAPINE Response in Biotype-1
  NCT04580134 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Georgia: Athens
• Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
  NCT05208190 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Georgia: Augusta